SCHEMBL8218840

SCHEMBL8218840

C[N+](C)(C)CCOC(=O)[C@@H](N)CCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.50
ADRA1A P35348 1/20 0.50
CHRM1 P11229 8/20 0.48
CHRM3 P20309 8/20 0.48
CHRM2 P08172 7/20 0.48
CHRM4 P08173 7/20 0.48
CHRM5 P08912 6/20 0.48
CHRNB2 P17787 4/20 0.48
CHRNA4 P43681 4/20 0.48
CHRNA7 P36544 3/20 0.48
HTR1A P08908 2/20 0.48
CYP2C19 P33261 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48
TSHR P16473 1/20 0.48
GRM8 O00222 1/20 0.47
GRM6 O15303 1/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8218838 0.88 ADRA2A (0.62) ADRA2AADRA1ACHRM1CHRM3CHRM2
Acetylcholine SCHEMBL28345020 0.84 CHRM1 (0.58) ADRA2AADRA1ACHRM1CHRM3CHRM2
SCHEMBL6033512 0.82 CHRM1 (0.52) ADRA2AADRA1ACHRM1CHRM3CHRM2
Acetylcholine SCHEMBL563048 0.82 CHRM1 (0.54) ADRA2AADRA1ACHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL27136777 0.82 GRM8 (0.40) ADRA2AADRA1ACHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL26985527 0.82 GRM8 (0.40) ADRA2AADRA1ACHRM1CHRM3CHRM2
SCHEMBL30321044 0.80 NOD1 (0.44) ADRA2AADRA1ACHRM1CHRM3CHRM2
SCHEMBL21051136 0.80 CYP1A2 (0.52) CYP2C19LMNAMAPTBLMTSHR
SCHEMBL9005556 0.80 CYP1A2 (0.52) CYP2C19LMNAMAPTBLMTSHR
SCHEMBL29232509 0.79 CHRM1 (0.48) ADRA2AADRA1ACHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059446-A1 MULTIVALENT IONIC LIQUIDS AS PROCESS AIDS FOR BITUMEN EXTRACTION STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED (GB) 2025-02-20 US claimed
CN-117343967-A Direct current is utilized in separationCoupling multienzyme system strengthening CO in sub-liquid 2 Reduction method and application 河南工业大学 2024-01-05 CN claimed
CN-116656753-A Efficient and continuous phospholipid type arachidonic acid enzymatic method 江南大学 2023-08-29 CN claimed
CN-114044852-B Polymerizable eutectic solvent, conductive elastomer and preparation method of conductive elastomer 江南大学 2022-11-22 CN claimed
CN-114044852-A Polymerizable eutectic solvent, conductive elastomer and preparation method thereof 江南大学 2022-02-15 CN claimed
CN-109627122-A A kind of biogas residue farmland compound fertilizer and preparation method thereof 山东省农业科学院作物研究所 2019-04-16 CN claimed
US-8187489-B1 Biodegradable ionic liquids for aircraft deicing THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-05-29 US claimed
US-20250059446-A1 MULTIVALENT IONIC LIQUIDS AS PROCESS AIDS FOR BITUMEN EXTRACTION STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED (GB) 2025-02-20 US disclosed
CN-114621984-B Method for synthesizing 1, 5-pentanediamine by using ionic liquid to strengthen lysine decarboxylase 中国科学院过程工程研究所 2025-01-28 CN disclosed
US-20240226045-A9 RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME BALCHEM CORPORATION 2024-07-11 US disclosed
WO-2024092005-A2 RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME BALCHEM CORPORATION (US) 2024-05-02 WO disclosed
US-20240130991-A1 RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME BALCHEM CORP (US) 2024-04-25 US disclosed
CN-116656753-A Efficient and continuous phospholipid type arachidonic acid enzymatic method 江南大学 2023-08-29 CN disclosed
US-20190330663-A1 Synthesis of bioproducts from lignin-derived aromatics by genetically modified microorganisms THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-10-31 US disclosed
CN-109627122-A A kind of biogas residue farmland compound fertilizer and preparation method thereof 山东省农业科学院作物研究所 2019-04-16 CN disclosed
WO-2018119152-A1 SYNTHESIS OF BIOPRODUCTS FROM LIGNIN-DERIVED AROMATICS BY GENETICALLY MODIFIED MICROORGANISMS NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (NTESS) (US) 2018-06-28 WO disclosed
US-20170247729-A1 SWITCHABLE IONIC LIQUIDS FOR BIOMASS PRETREATMENT AND ENZYMATIC HYDROLYSIS UNITED STATES DEPARTMENT OF ENERGY 2017-08-31 US disclosed
WO-2016070125-A1 SWITCHABLE IONIC LIQUIDS FOR BIOMASS PRETREATMENT AND ENZYMATIC HYDROLYSIS SANDIA CORPORATION (US) 2016-05-06 WO disclosed
US-8187489-B1 Biodegradable ionic liquids for aircraft deicing THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-05-29 US disclosed
US-5187093-A Pure culture from which microorganisms which are stable, do not catabolize carnitine and grow with betaine are chosen LONZA LTD. (CH) 1993-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190330663-A1 Synthesis of bioproducts from lignin-derived aromatics by genetically modified microorganisms DCXR, DDC, PAH ADRA2A 2640/4885ADRA1A 2509/4885CHRM1 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.